Drugs News and Research

RSS

Molecular reporters produce fluorescence to expose the allies of tumor cells

Glioblastoma is the most common malignant brain tumor in adults. Roughly five in every 100,000 people develop this type of cancer each year.

23 Dec 2020

COVID-19 severity could be linked to genetic variance

A new study describes some potentially important genetic factors in the host that may shape the clinical symptoms and signs of the disease.

23 Dec 2020

Researchers use fruit fly model to understand COVID-19-related neurological complications

Researchers claim to have reproduced disease mechanisms due to coronavirus disease 2019 (COVID-19) in the fruit fly, Drosophila, while also providing proof of the efficacy of one drug against these disease processes. If validated, these findings represent a new understanding of how the virus causes neurological symptoms that could help develop more effective therapies.

23 Dec 2020

Researchers test effects of full doses of anticoagulants in COVID-19 patients

Three clinical trial platforms working together to test the effects of full doses of anticoagulants (blood thinners) in COVID-19 patients have paused enrollment for one group of patients.

23 Dec 2020

Changes in consciousness linked to the same brain network for sleep and anesthesia

The loss and return of consciousness is linked to the same network of brain regions for both sleep and anesthesia, according to new research published in JNeurosci.

23 Dec 2020

New therapeutic strategy designed to improve kidney function after lung transplantation

The Covid-19 pandemic shows the importance of medical research in the treatment of lung diseases. The Medical University of Vienna is renowned the world over in the field of lung transplantation medicine.

23 Dec 2020

Phase 2/3 COVID-19 study evaluates safety, potential identification of preliminary efficacy signals

Top-line data from the 270-patient global Phase 2/3 COVID-19 study expected Q1/2021. Top-line data from the 40-patient U.S. Phase 2 study of opaganib in severe COVID-19 expected in the coming days; this non-powered study was designed to evaluate safety and potential identification of preliminary efficacy signals in support of the global Phase 2/3 study of opaganib.

23 Dec 2020

Congress extends Medicare coverage of immunosuppressive drugs for kidney transplant

An estimated 375 adult kidney transplant recipients lose their transplant every year due to a lack of coverage of immunosuppressive medications after the prior 36-month Medicare coverage period.

23 Dec 2020

Long-term opioid use cannot treat chronic pain, has serious health consequences

A broken heart is often harder to heal than a broken leg. Now researchers say that a broken heart can contribute to lasting chronic pain.

22 Dec 2020

Early clinical data demonstrates the efficacy of existing drug in treating COVID-19

In what has the potential to significantly change how Corona patients are being treated and the severity of the disease, research spearheaded at Jerusalem's Hebrew University gathered early clinical evidence demonstrating the efficacy of an existing drug in treating COVID-19.

22 Dec 2020

Truncating mutation locations tied to diversity, severity of autism symptoms

One of the most recognizable characteristics of autism is an amazing diversity of associated behavioral symptoms. Clinicians view autism as a broad spectrum of related disorders, and the origin of the disease's heterogeneity has puzzled scientists, doctors, and affected families for decades.

22 Dec 2020

New drug starves cancer cells by attacking mitochondria

A newly developed compound starves cancer cells by attacking their "power plants" - the so-called mitochondria.

22 Dec 2020

Researchers control cardiac waves with light to study abnormally rapid heart rhythms

Over 300,000 people die each year in the U.S. due to sudden cardiac death. In many cases, sudden cardiac death is caused by abnormally rapid heart rhythms called tachycardias, which means the heart cannot pump adequate blood to the body.

22 Dec 2020

New drug combination improves blood glucose control and weight loss in mice

Scientists have shown that adding an experimental cancer drug to a widely used diabetes treatment improves blood glucose control and weight loss in mice, according to a study published today in eLife.

22 Dec 2020

FDA issues warning letters to companies illegally selling unapproved CBD products

Today, the U.S. Food and Drug Administration issued five warning letters to companies for selling products containing cannabidiol (CBD) in ways that violate the Federal Food, Drug, and Cosmetic Act (FD&C Act).

22 Dec 2020

Democrats are running hard on health care in Georgia’s Senate runoffs. Republicans? Not so much.

Vice President Mike Pence was the clear celebrity draw at a Nov. 20 campaign event for Georgia's two incumbent U.S. senators, Kelly Loeffler and David Perdue. Both Republicans are fighting to keep their seats against two Democratic challengers in the runoff election set for Jan. 5.

22 Dec 2020

Comparing Google AI and human intelligence for the forecasting of COVID-19

Junko Kurita et al. from Japan have compared Google AI forecasting with a statistical model by human intelligence and recently presented it in a preprint medRxiv* paper.

22 Dec 2020

Immune-inflammatory mediators indicate that rejection and tissue injury can be avoided with drugs

Immune inflammatory mediators are critical in pathology, transplantation, and regenerative medicine, scientists report in The American Journal of Pathology

22 Dec 2020

Researchers have a promising lead on COVID-19 treatment

By taking a lesson from prostate cancer, researchers now have a promising lead on treatment for COVID-19. Two proteins, ACE2 and TMPRSS2, help the coronavirus gain entry and replicate within cells. TMPRSS2 is well-known to Arul Chinnaiyan, M.D., Ph.D. His lab discovered that TMPRSS2 fuses with the ETS gene to drive more than half of all prostate cancers. They also knew that TMPRSS2 was regulated by the androgen receptor.

21 Dec 2020

Study depicts previously unknown molecular mechanism underlying healthy brain development

A research team led by Michael Fox, a professor at the Fralin Biomedical Research Institute at VTC, has identified the type of brain cell that produces collagen 19, a protein that is crucial for the formation of inhibitory circuits in the brain.

21 Dec 2020

Drugs News and Research

Molecular reporters produce fluorescence to expose the allies of tumor cells

COVID-19 severity could be linked to genetic variance

Researchers use fruit fly model to understand COVID-19-related neurological complications

Researchers test effects of full doses of anticoagulants in COVID-19 patients

Changes in consciousness linked to the same brain network for sleep and anesthesia

New therapeutic strategy designed to improve kidney function after lung transplantation

Phase 2/3 COVID-19 study evaluates safety, potential identification of preliminary efficacy signals

Congress extends Medicare coverage of immunosuppressive drugs for kidney transplant

Long-term opioid use cannot treat chronic pain, has serious health consequences

Early clinical data demonstrates the efficacy of existing drug in treating COVID-19

Truncating mutation locations tied to diversity, severity of autism symptoms

New drug starves cancer cells by attacking mitochondria

Researchers control cardiac waves with light to study abnormally rapid heart rhythms

New drug combination improves blood glucose control and weight loss in mice

FDA issues warning letters to companies illegally selling unapproved CBD products

Democrats are running hard on health care in Georgia’s Senate runoffs. Republicans? Not so much.

Comparing Google AI and human intelligence for the forecasting of COVID-19

Immune-inflammatory mediators indicate that rejection and tissue injury can be avoided with drugs

Researchers have a promising lead on COVID-19 treatment

Study depicts previously unknown molecular mechanism underlying healthy brain development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News